Mark Hunter, MD
Mark Hunter, MD
Director, Gynecologic Oncology, Assistant Professor, OB/GYN
University of Missouri, Columbia
115 Business Loop 70 West
Columbia,
MO
United States
65203
Papers:
A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study